Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 12, Number 3, March 2020, pages 180-183

Chronic Kidney Disease in Patients Undergoing Cardiac Device Placement: Results of a Retrospective Study

Tables

Table 1. Demographics of Patient Undergoing Cardiac Device Placement (n = 688)
 
Age73.9 years
Gender
  Men414 (60%)
  Women274 (40%)
Race
  White636 (92.4%)
  Black40 (5.8%)
  Asian4 (0.6%)
  Hispanic3 (0.4%)
  Other5 (0.7%)
Congestive heart failure309 (45%)
Diabetes165 (24%)
Renal disease227 (33%)
Dialysis20 (3%)
Cardiovascular disease399 (58%)
Cerebrovascular accident114 (17%)
Peripheral vascular disease46 (7%)
Lung disease135 (20%)
Hyperlipidemia457 (66%)
Hypertension524 (76%)

 

Table 2. Types of Cardiac Device and Sites of Access (n = 688)
 
Types of Access
  Radial5 (0.7%)
  Femoral84 (12%)
  Axillary222 (32%)
  Subclavian324 (47%)
  Subcutaneous50 (7%)
  Other3 (0.4%)
Procedure Types
  Insertion or replacement of atrial and ventricular leads272 (39.5%)
  Loop recorder implant145 (21.1%)
  Loop recorder explant23 (3.3%)
  Leadless permanent pacemaker28 (4.1%)
  Watchman43 (6.3%)
  Lead repositioning9 (1.3%)
  Generator changes76 (11.0%)
  New bi-ventricular system49 (7.1%)
  Upgrade to bi-ventricular system24 (6.2%)
  Other19 (2.8%)

 

Table 3. Stages of CKD in Patients’ Who Underwent Cardiac Device Placement
 
Stages of CKDNumber of patientseGFRa
Stage 1 and 2 CKD are not included.CKD: chronic kidney disease; eGFR: estimated glomerular filtration rate. aeGFR reported by labs > 60 mL/min.
Stage 3A116 (17%)45 - 59 mL/min
Stage 3B69 (10%)30 - 44 mL/min
Stage 423(3%)15 - 29 mL/min
Stage 519 (3%)< 15 mL/min